3M季绩胜预期 料今季口罩需求持续增加
3M(MMM.US)第三季盈利下跌11%至14.1亿美元,受累於经营成本增长近8%。每股盈利为2.43美元,优於市场预期的2.26美元。收入增长4.5%至83.5亿美元,同样胜预期。
上季3M在4个主要业务当中有3个的销售额均有所增长,当中医疗保健业绩收入增长25.5%。3M表示,预计口罩的需求会在第四季度持续增加,今年有望生产20亿个N95口罩。
3M预计全年资本开支介乎14亿至15亿美元,而此前的预测为14亿美元。不过由於疫情带来的不确定性,公司拒绝提供今年的其他预测。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.